Humacyte (HUMA)
Humacyte on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).
30.3M
Short interest
settlement 2026-10-15
3.7
Days to cover
-3.6 days vs prior
54.6%
Short share of volume
2026-11-02
99,686
Fails to deliver
settlement 2026-10-13
Wed 11 Nov
Next earnings
estimated date
$30K
Insider flow, 90 days
3 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in HUMA is 30,251,083 shares, down 1,556,483 shares over the last month. Over the last 48 readings it ranged from 17,250,350 shares (31 October 2024) to 44,844,793 shares (15 April 2026). At the reported average volume of 8.3M shares a day that is 3.7 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/huma" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 30,251,083 | +2.9% | 8,274,362 | 3.66 |
| 2026-09-30 | 29,399,293 | -7.6% | 4,024,163 | 7.31 |
| 2026-09-15 | 31,807,566 | +6.7% | 4,387,750 | 7.25 |
| 2026-08-31 | 29,813,381 | -6.7% | 8,761,921 | 3.40 |
| 2026-08-14 | 31,939,257 | +1.4% | 9,500,655 | 3.36 |
| 2026-07-31 | 31,488,080 | -2.5% | 4,552,596 | 6.92 |
| 2026-07-15 | 32,283,805 | +2.2% | 9,658,029 | 3.34 |
| 2026-06-30 | 31,597,133 | -13.9% | 25,184,498 | 1.25 |
| 2026-06-15 | 36,706,340 | -8.6% | 8,946,847 | 4.10 |
| 2026-05-29 | 40,140,620 | -2.5% | 6,537,068 | 6.14 |
| 2026-05-15 | 41,159,014 | -7.9% | 7,933,504 | 5.19 |
| 2026-04-30 | 44,703,015 | -0.3% | 4,464,779 | 10.01 |
| 2026-04-15 | 44,844,793 | +6.2% | 4,770,787 | 9.40 |
| 2026-03-31 | 42,223,438 | +3.8% | 13,920,612 | 3.03 |
| 2026-03-13 | 40,676,377 | +6.6% | 3,927,526 | 10.36 |
| 2026-02-27 | 38,162,880 | -2.6% | 4,297,365 | 8.88 |
| 2026-02-13 | 39,193,932 | +0.9% | 7,507,477 | 5.22 |
| 2026-01-30 | 38,837,697 | +4.5% | 4,823,532 | 8.05 |
| 2026-01-15 | 37,152,671 | +2.2% | 4,903,532 | 7.58 |
| 2025-12-31 | 36,355,101 | +2.7% | 5,620,744 | 6.47 |
| 2025-12-15 | 35,398,643 | +2.1% | 3,823,799 | 9.26 |
| 2025-11-28 | 34,652,802 | +3.7% | 4,742,543 | 7.31 |
| 2025-11-14 | 33,414,650 | +3.6% | 5,311,260 | 6.29 |
| 2025-10-31 | 32,241,263 | +18.4% | 4,117,825 | 7.83 |
| 2025-10-15 | 27,220,587 | -5.5% | 10,340,766 | 2.63 |
| 2025-09-30 | 28,794,874 | -16.2% | 3,869,340 | 7.44 |
| 2025-09-15 | 34,356,507 | +2.2% | 2,303,402 | 14.92 |
| 2025-08-29 | 33,603,019 | -1.9% | 4,206,086 | 7.99 |
| 2025-08-15 | 34,251,609 | +7.5% | 7,374,269 | 4.64 |
| 2025-07-31 | 31,871,443 | -2.6% | 4,044,015 | 7.88 |
| 2025-07-15 | 32,720,780 | +7.0% | 4,267,060 | 7.67 |
| 2025-06-30 | 30,579,985 | +7.6% | 2,494,493 | 12.26 |
| 2025-06-13 | 28,426,146 | -10.6% | 4,278,773 | 6.64 |
| 2025-05-30 | 31,799,416 | +4.8% | 5,434,232 | 5.85 |
| 2025-05-15 | 30,350,872 | +20.7% | 4,995,440 | 6.08 |
| 2025-04-30 | 25,152,561 | -3.6% | 2,364,347 | 10.64 |
| 2025-04-15 | 26,087,030 | -3.9% | 5,694,523 | 4.58 |
| 2025-03-31 | 27,135,345 | +2.0% | 6,357,180 | 4.27 |
| 2025-03-14 | 26,600,632 | +4.4% | 2,171,262 | 12.25 |
| 2025-02-28 | 25,475,658 | +5.8% | 2,428,438 | 10.49 |
| 2025-02-14 | 24,078,378 | +0.2% | 1,571,070 | 15.33 |
| 2025-01-31 | 24,038,073 | -6.2% | 1,741,843 | 13.80 |
| 2025-01-15 | 25,637,541 | -13.4% | 3,504,517 | 7.32 |
| 2024-12-31 | 29,620,351 | +34.9% | 12,347,612 | 2.40 |
| 2024-12-13 | 21,962,264 | +8.0% | 2,413,868 | 9.10 |
| 2024-11-29 | 20,333,918 | +6.2% | 2,952,781 | 6.89 |
| 2024-11-15 | 19,143,298 | +11.0% | 3,525,404 | 5.43 |
| 2024-10-31 | 17,250,350 | +3.5% | 3,641,997 | 4.74 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of HUMA volume is 54.6%, down 3.1 points over the last five sessions. Over the last 30 readings it ranged from 39.0% (29 October 2026) to 85.2% (12 October 2026). The latest reading is 6.2 points below the 30-session average of 60.8%, on 3.5M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 1.9M | 3.5M | 54.6% | 470,812 |
| 2026-10-30 | 2.8M | 3.7M | 75.0% | 388,038 |
| 2026-10-29 | 886K | 2.3M | 39.0% | 18,237 |
| 2026-10-28 | 923K | 1.6M | 56.0% | 28,491 |
| 2026-10-27 | 1.2M | 2.3M | 53.1% | 287,657 |
| 2026-10-26 | 1.2M | 2.1M | 57.8% | 26,733 |
| 2026-10-23 | 791K | 1.6M | 48.3% | 52,522 |
| 2026-10-22 | 823K | 1.3M | 62.3% | 0 |
| 2026-10-21 | 1.7M | 2.7M | 62.4% | 5,200 |
| 2026-10-20 | 2.0M | 3.4M | 58.6% | 21,796 |
| 2026-10-19 | 1.5M | 2.8M | 54.4% | 29,020 |
| 2026-10-16 | 2.4M | 3.7M | 63.2% | 217 |
| 2026-10-15 | 8.7M | 15.4M | 56.5% | 182,922 |
| 2026-10-14 | 1.8M | 3.7M | 48.8% | 29,091 |
| 2026-10-13 | 5.9M | 9.6M | 61.4% | 10,608 |
| 2026-10-12 | 11.7M | 13.8M | 85.2% | 1,692,866 |
| 2026-10-09 | 4.0M | 6.3M | 63.8% | 597,195 |
| 2026-10-08 | 2.0M | 3.1M | 66.8% | 27,514 |
| 2026-10-07 | 1.5M | 2.6M | 58.1% | 13,197 |
| 2026-10-06 | 1.7M | 2.4M | 70.4% | 1,000 |
| 2026-10-05 | 2.6M | 4.0M | 66.5% | 9,849 |
| 2026-10-02 | 2.1M | 2.8M | 74.3% | 0 |
| 2026-10-01 | 805K | 1.6M | 51.5% | 10,402 |
| 2026-09-30 | 2.0M | 3.7M | 54.1% | 3 |
| 2026-09-29 | 1.5M | 2.1M | 70.5% | 0 |
| 2026-09-28 | 1.5M | 2.9M | 52.5% | 1,000 |
| 2026-09-25 | 1.1M | 1.7M | 67.3% | 0 |
| 2026-09-24 | 1.2M | 1.8M | 69.1% | 200 |
| 2026-09-23 | 1.5M | 2.0M | 73.8% | 0 |
| 2026-09-22 | 1.2M | 2.3M | 50.2% | 3,710 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 13 October 2026, the fails-to-deliver balance in HUMA is 99,686 shares, up 36,984 shares over the last settlement date. Over the last 30 readings it ranged from 45 shares (28 July 2026) to 594,794 shares (2 September 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-13 | 99,686 | $0.39 | $39K |
| 2026-10-07 | 62,702 | $0.48 | $30K |
| 2026-10-02 | 159,976 | $0.50 | $80K |
| 2026-10-01 | 159,975 | $0.52 | $83K |
| 2026-09-30 | 613 | $0.53 | $325 |
| 2026-09-29 | 100 | $0.55 | $55 |
| 2026-09-24 | 746 | $0.57 | $425 |
| 2026-09-23 | 91,971 | $0.58 | $53K |
| 2026-09-18 | 1,754 | $0.58 | $1K |
| 2026-09-09 | 36,754 | $0.59 | $22K |
| 2026-09-08 | 14,140 | $0.60 | $8K |
| 2026-09-03 | 98,820 | $0.60 | $59K |
| 2026-09-02 | 594,794 | $0.57 | $339K |
| 2026-09-01 | 451,255 | $0.60 | $271K |
| 2026-08-31 | 516,212 | $0.65 | $336K |
| 2026-08-21 | 18,085 | $0.68 | $12K |
| 2026-08-19 | 142,798 | $0.58 | $83K |
| 2026-08-14 | 523,072 | $0.55 | $288K |
| 2026-08-04 | 4,227 | $0.69 | $3K |
| 2026-07-30 | 2,953 | $0.62 | $2K |
| 2026-07-29 | 43,822 | $0.63 | $28K |
| 2026-07-28 | 45 | $0.67 | $30 |
| 2026-07-27 | 45,932 | $0.62 | $28K |
| 2026-07-24 | 154,073 | $0.64 | $99K |
| 2026-07-23 | 445 | $0.64 | $285 |
| 2026-07-20 | 73,633 | $0.66 | $49K |
| 2026-07-17 | 619 | $0.66 | $409 |
| 2026-07-16 | 19,887 | $0.68 | $14K |
| 2026-07-15 | 600 | $0.71 | $426 |
| 2026-07-10 | 32,218 | $0.70 | $23K |
Insider trades
SEC Form 4, newest first. JSONInsiders at HUMA reported 3 open-market buys worth $30K in the last 90 days and no open-market sells. Latest filing: Jones Keith Anthony (Director) on 2026-09-14.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | Jones Keith Anthony | Director | Buy | 10K | $0.56 | $6K | 50K |
| 2026-08-20 | Jones Keith Anthony | Director | Buy | 10K | $0.69 | $7K | 40K |
| 2026-08-17 | Jones Keith Anthony | Director | Buy | 30K | $0.59 | $18K | 30K |
| 2026-05-19 | Sebelius Kathleen | Director | Buy | 57K | $0.88 | $50K | 148K |
| 2026-05-18 | Parikh Shamik J | Chief Medical Officer | Sell | 46K | $0.90 | $41K | 273K |
| 2026-05-18 | Sander Dale A. | CFO and Chief Corp. Dev. Off | Sell | 46K | $0.90 | $41K | 267K |
| 2026-05-18 | Constantino Michael T. | Director | Buy | 11K | $0.89 | $10K | 44K |
| 2025-11-16 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Grant | 311K | $0.00 | $0 | 313K |
| 2025-11-16 | Parikh Shamik J | Chief Medical Officer | Grant | 311K | $0.00 | $0 | 319K |
| 2025-08-20 | Niklason Laura E | President, CEO and Director | Sell | 592K | $1.58 | $935K | 0 |
| 2025-08-20 | Dougan Brady W | Director | Sell | 592K | $1.58 | $935K | 0 |
| 2025-08-19 | Niklason Laura E | President, CEO and Director | Sell | 1.1M | $1.63 | $1.8M | 592K |
| 2025-08-19 | Dougan Brady W | Director | Sell | 1.1M | $1.63 | $1.8M | 592K |
| 2025-08-18 | Niklason Laura E | President, CEO and Director | Sell | 549K | $1.83 | $1.0M | 1.7M |
| 2025-08-18 | Dougan Brady W | Director | Sell | 549K | $1.83 | $1.0M | 1.7M |
| 2025-04-14 | Scheessele William John | Chief Commercial Officer | Buy | 6K | $1.54 | $10K | 22K |
| 2025-04-10 | Parikh Shamik J | Chief Medical Officer | Buy | 8K | $1.55 | $12K | 8K |
| 2025-04-10 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Buy | 20K | $1.53 | $31K | 41K |
| 2025-04-08 | Green Charles Bruce | Director | Buy | 6K | $1.29 | $8K | 8K |
| 2025-04-08 | Sebelius Kathleen | Director | Buy | 50K | $1.32 | $66K | 91K |
| 2025-04-07 | Constantino Michael T. | Director | Buy | 16K | $1.26 | $20K | 33K |
| 2024-12-04 | Constantino Michael T. | Director | Buy | 5K | $4.39 | $20K | 17K |
| 2024-11-20 | Dougan Brady W | Director | Sell | 261K | $4.40 | $1.2M | 1.7M |
| 2024-11-20 | Niklason Laura E | President, CEO and Director | Sell | 261K | $4.40 | $1.2M | 1.7M |
| 2024-11-19 | Dougan Brady W | Director | Sell | 427K | $4.34 | $1.9M | 2.0M |
| 2024-11-19 | Niklason Laura E | President, CEO and Director | Sell | 427K | $4.34 | $1.9M | 2.0M |
| 2024-11-19 | Dougan Brady W | Director | Buy | 2K | $4.44 | $8K | 244K |
| 2024-11-19 | Niklason Laura E | President, CEO and Director | Buy | 2K | $4.44 | $8K | 244K |
| 2024-11-18 | Dougan Brady W | Director | Sell | 811K | $4.44 | $3.6M | 2.4M |
| 2024-11-18 | Niklason Laura E | President, CEO and Director | Sell | 811K | $4.44 | $3.6M | 2.4M |
| 2024-09-13 | Green Charles Bruce | Director | Exercise or conversion | 1K | $4.09 | $5K | 2K |
| 2024-09-10 | Niklason Laura E | President, CEO and Director | Sell | 289K | $5.23 | $1.5M | 3.2M |
| 2024-09-10 | Dougan Brady W | Director | Sell | 289K | $5.23 | $1.5M | 3.2M |
| 2024-09-10 | Sebelius Kathleen | Director | Sell | 4K | $5.41 | $20K | 40K |
| 2024-09-10 | Sebelius Kathleen | Director | Exercise or conversion | 5K | $4.34 | $20K | 44K |
| 2024-09-10 | Sebelius Kathleen | Director | Exercise or conversion | 2K | $3.35 | $8K | 43K |
| 2024-09-10 | Sebelius Kathleen | Director | Sell | 2K | $5.39 | $8K | 41K |
| 2024-09-09 | Niklason Laura E | President, CEO and Director | Sell | 158K | $5.42 | $855K | 3.5M |
| 2024-09-09 | Dougan Brady W | Director | Sell | 158K | $5.42 | $855K | 3.5M |
| 2024-08-29 | Niklason Laura E | President, CEO and Director | Sell | 352K | $6.35 | $2.2M | 3.7M |
| 2024-08-29 | Dougan Brady W | Director | Sell | 352K | $6.35 | $2.2M | 3.7M |
| 2024-08-29 | Dougan Brady W | Director | Buy | 1K | $6.55 | $8K | 242K |
| 2024-08-29 | Niklason Laura E | President, CEO and Director | Buy | 1K | $6.55 | $8K | 242K |
| 2024-08-28 | Niklason Laura E | President, CEO and Director | Sell | 277K | $6.47 | $1.8M | 4.0M |
| 2024-08-28 | Dougan Brady W | Director | Sell | 277K | $6.47 | $1.8M | 4.0M |
| 2024-08-27 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Exercise or conversion | 39K | $2.56 | $101K | 41K |
| 2024-08-27 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Sell | 39K | $6.68 | $263K | 2K |
| 2024-08-27 | Niklason Laura E | President, CEO and Director | Sell | 253K | $6.71 | $1.7M | 4.3M |
| 2024-08-27 | Dougan Brady W | Director | Sell | 253K | $6.71 | $1.7M | 4.3M |
| 2024-08-15 | Constantino Michael T. | Director | Buy | 3K | $6.29 | $19K | 12K |
| 2024-06-14 | Sebelius Kathleen | Director | Exercise or conversion | 39K | $2.56 | $101K | 39K |
| 2024-06-12 | Dougan Brady W | Director | Sell | 272K | $7.30 | $2.0M | 4.6M |
| 2024-06-12 | Niklason Laura E | President, CEO and Director | Sell | 272K | $7.30 | $2.0M | 4.6M |
| 2024-06-11 | Dougan Brady W | Director | Sell | 77K | $7.02 | $538K | 4.8M |
| 2024-06-11 | Dougan Brady W | Director | Sell | 282K | $7.09 | $2.0M | 4.9M |
| 2024-06-11 | Niklason Laura E | President, CEO and Director | Sell | 282K | $7.09 | $2.0M | 4.9M |
| 2024-06-11 | Niklason Laura E | President, CEO and Director | Sell | 77K | $7.02 | $538K | 4.8M |
| 2024-06-04 | Dougan Brady W | Director | Sell | 2K | $7.28 | $13K | 5.2M |
| 2024-06-04 | Niklason Laura E | President, CEO and Director | Sell | 2K | $7.28 | $13K | 5.2M |
| 2024-06-04 | Dougan Brady W | Director | Buy | 2K | $6.35 | $15K | 241K |
| 2024-06-04 | Niklason Laura E | President, CEO and Director | Buy | 2K | $6.35 | $15K | 241K |
| 2024-06-03 | Dougan Brady W | Director | Buy | 2K | $7.37 | $15K | 238K |
| 2024-06-03 | Niklason Laura E | President, CEO and Director | Buy | 2K | $7.37 | $15K | 238K |
| 2024-06-03 | Dougan Brady W | Director | Sell | 190K | $7.42 | $1.4M | 5.2M |
| 2024-06-03 | Niklason Laura E | President, CEO and Director | Sell | 190K | $7.42 | $1.4M | 5.2M |
| 2024-05-31 | Prichard Heather Ledbetter | Chief Operating Officer | Sell | 3K | $9.41 | $25K | 0 |
| 2024-05-31 | Dougan Brady W | Director | Sell | 717K | $7.78 | $5.6M | 5.5M |
| 2024-05-31 | Dougan Brady W | Director | Sell | 93K | $8.93 | $832K | 5.4M |
| 2024-05-31 | Niklason Laura E | President, CEO and Director | Sell | 717K | $7.78 | $5.6M | 5.5M |
| 2024-05-31 | Niklason Laura E | President, CEO and Director | Sell | 93K | $8.93 | $832K | 5.4M |
| 2024-05-30 | Prichard Heather Ledbetter | Chief Operating Officer | Sell | 48K | $8.32 | $401K | 3K |
| 2024-05-30 | Prichard Heather Ledbetter | Chief Operating Officer | Sell | 62K | $7.71 | $478K | 3K |
| 2024-05-30 | Prichard Heather Ledbetter | Chief Operating Officer | Exercise or conversion | 79K | $2.56 | $202K | 81K |
| 2024-05-30 | Prichard Heather Ledbetter | Chief Operating Officer | Exercise or conversion | 48K | $3.07 | $148K | 51K |
| 2024-05-30 | Prichard Heather Ledbetter | Chief Operating Officer | Sell | 79K | $8.36 | $659K | 3K |
| 2024-05-20 | Green Charles Bruce | Director | Exercise or conversion | 600 | $4.09 | $2K | 1K |
| 2024-05-20 | Wallace Max N. | Director | Buy | 4K | $6.21 | $25K | 4K |
| 2024-05-20 | Wallace Max N. | Director | Buy | 4K | $6.29 | $25K | 4K |
| 2024-05-17 | Green Charles Bruce | Director | Exercise or conversion | 600 | $4.09 | $2K | 600 |
| 2024-05-15 | Binder Gordon M | Director | Buy | 50K | $6.57 | $329K | 50K |
| 2024-05-15 | Binder Gordon M | Director | Buy | 50K | $6.78 | $339K | 160K |
| 2023-11-21 | Wallace Max N. | Director | Exercise or conversion | 7K | $1.19 | $8K | 57K |
| 2023-10-10 | Niklason Laura E | President, CEO and Director | Exercise or conversion | 114K | $1.19 | $136K | 1.4M |
| 2023-10-10 | Dougan Brady W | Director | Exercise or conversion | 114K | $1.19 | $136K | 1.4M |
| 2023-09-14 | Dougan Brady W | Director | Sell | 2.0M | $2.78 | $5.6M | 6.2M |
| 2023-09-14 | Niklason Laura E | President, CEO and Director | Sell | 2.0M | $2.78 | $5.6M | 6.2M |
| 2023-08-21 | Ayabudge LLC | TenPercentOwner | Sell | 602K | $3.39 | $2.0M | 8.2M |
| 2023-08-21 | Dougan Brady W | Director | Sell | 602K | $3.39 | $2.0M | 8.2M |
| 2023-08-21 | Niklason Laura E | President, CEO and Director | Sell | 602K | $3.39 | $2.0M | 8.2M |
| 2023-08-18 | Ayabudge LLC | TenPercentOwner | Sell | 627K | $3.57 | $2.2M | 8.8M |
| 2023-08-18 | Dougan Brady W | Director | Sell | 627K | $3.57 | $2.2M | 8.8M |
| 2023-08-18 | Niklason Laura E | President, CEO and Director | Sell | 627K | $3.57 | $2.2M | 8.8M |
| 2023-08-17 | Ayabudge LLC | TenPercentOwner | Sell | 570K | $3.68 | $2.1M | 9.4M |
| 2023-08-17 | Dougan Brady W | Director | Sell | 570K | $3.68 | $2.1M | 9.4M |
| 2023-08-17 | Niklason Laura E | President, CEO and Director | Sell | 570K | $3.68 | $2.1M | 9.4M |
| 2023-06-15 | Ayabudge LLC | TenPercentOwner | Sell | 500K | $3.12 | $1.6M | 10.0M |
| 2023-06-15 | Dougan Brady W | Director,TenPercentOwner | Sell | 500K | $3.12 | $1.6M | 10.0M |
| 2023-06-15 | Niklason Laura E | President, CEO and Director | Sell | 500K | $3.12 | $1.6M | 10.0M |
| 2023-06-13 | Ayabudge LLC | TenPercentOwner | Sell | 4.9M | $2.60 | $12.7M | 10.5M |
| 2023-06-13 | Dougan Brady W | Director,TenPercentOwner | Sell | 4.9M | $2.60 | $12.7M | 10.5M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON2 Form 144 notices on file for HUMA worth $82K at the prices reported; 0 in the last 90 days worth $0. Latest: Sander Dale A. filed on 2026-05-18 to sell 45,887 shares ($41K) from 2026-05-18.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-05-18 | Sander Dale A.Officer | 46K | $41K | 0.021% | 2026-05-18 | Fidelity Brokerage Services LLC |
| 2026-05-18 | Parikh Shamik JOfficer | 46K | $41K | 0.021% | 2026-05-18 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSONNo holder on file reports 5% or more of HUMA in its latest filing.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-18 | 13D/Ano. 11 | Fresenius Medical Care Holdings, Inc.corporation | 13.6M | 4.9% | 2026-08-14 |
| 2026-08-18 | 13D/Ano. 11 | Fresenius Medical Care AGcorporation | 13.6M | 4.9% | 2026-08-14 |
| 2026-07-28 | 13G/Ano. 1 | BlackRock, Inc.parent holding company | 4.1M | 1.5% | 2026-06-30 |
| 2026-06-22 | 13G | Anthony A. Yoseloffindividual | 12.8M | 4.7% | 2026-06-12 |
| 2026-06-22 | 13G | Davidson Kempner Capital Management LPpartnership | 12.8M | 4.7% | 2026-06-12 |
| 2026-06-22 | 13G | Davidson Kempner Arbitrage, Equities & Relative Value LPpartnership | 12.6M | 4.7% | 2026-06-12 |
| 2026-06-22 | 13G | M.H. Davidson & Co.partnership | 233K | 0.1% | 2026-06-12 |
13F holders
Tracked managers holding HUMA at their latest 13F. JSON5 of the 30 tracked managers held HUMA at their latest 13F, $4.7M in total at quarter-end prices. AQR Capital Management is the largest at $2.0M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 2.6M | $2.0M | 0.00% | +672K |
| Millennium Management | 2026-06-30 | 1.9M | $1.5M | 0.00% | +1.8M |
| Citadel Advisors | 2026-06-30 | 1.4M | $1.1M | 0.00% | new |
| Point72 Asset Management | 2026-06-30 | 54K | $42K | 0.00% | new |
| Two Sigma Investments | 2026-06-30 | 30K | $23K | 0.00% | -148K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Humacyte in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Humacyte (HUMA), SEC CIK 1818382, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-05-18.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-18.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-14.JSON and CSV
- Company record
- EDGAR filing index for CIK 1818382Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as biological products, (no diagnostic substances)
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of HUMA is sold short?
30,251,083 shares were held short at the 2026-10-15 settlement, 3.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is HUMA's daily short volume?
On 2026-11-02, 1,908,507 of the 3,494,066 HUMA shares reported to FINRA were sold short, 54.6% of the day's reported volume. Short volume is a flow for one day, not a position.
Does HUMA have fails to deliver?
The SEC's latest file shows 99,686 HUMA shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are HUMA insiders buying or selling?
Insiders at HUMA reported 3 open-market buys worth $30K in the last 90 days and no open-market sells. Latest filing: Jones Keith Anthony (Director) on 2026-09-14.
Have HUMA insiders filed to sell?
2 Form 144 notices on file for HUMA worth $82K at the prices reported; 0 in the last 90 days worth $0. Latest: Sander Dale A. filed on 2026-05-18 to sell 45,887 shares ($41K) from 2026-05-18.
Who owns 5% or more of HUMA?
No holder on file reports 5% or more of HUMA in its latest filing.
Which tracked 13F managers own HUMA?
5 of the 30 tracked 13F managers held HUMA shares at their latest filing, $4.7M in all. The largest: Cliff Asness's AQR Capital Management (2.6M shares, $2.0M), Izzy Englander's Millennium Management (1.9M shares, $1.5M), Ken Griffin's Citadel Advisors (1.4M shares, $1.1M), Steve Cohen's Point72 Asset Management (54K shares, $42K), Two Sigma Investments (30K shares, $23K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.